COVID-19 Vaccine Maker AstraZeneca Doubles Profit
AstraZeneca, the British maker of a COVID-19 vaccine with Oxford University, said Thursday its 2020 net profit more than doubled to $3.2 billion thanks to strong sales growth of cancer drugs.
Profit after tax, equivalent to 2.64 billion…